• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

2-(Piperidin-1-yl)pyridin-3-amine: An Overview of a Promising Compound (CAS No. 5028-1-4)

2-(Piperidin-1-yl)pyridin-3-amine, also known by its CAS number 5028-14-8, is a versatile compound with significant potential in various fields, including medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has garnered considerable attention due to its potential therapeutic applications and biological activities.

The molecular structure of 2-(piperidin-1-yl)pyridin-3-amine consists of a pyridine ring substituted with a piperidine group at the 2-position and an amine group at the 3-position. This arrangement confers the molecule with distinct chemical properties that make it an attractive candidate for drug development. The compound's ability to interact with various biological targets, such as receptors and enzymes, has been extensively studied in recent years.

In the realm of medicinal chemistry, 2-(piperidin-1-yl)pyridin-3-amine has shown promise in the treatment of neurological disorders. Research has indicated that this compound can modulate the activity of certain neurotransmitter systems, particularly those involving serotonin and dopamine. These neurotransmitters play crucial roles in mood regulation, cognitive function, and motor control. By targeting these systems, 2-(piperidin-1-yl)pyridin-3-amine may offer therapeutic benefits for conditions such as depression, anxiety, and Parkinson's disease.

Recent studies have also explored the potential of 2-(piperidin-1-yl)pyridin-3-amine in cancer research. Preliminary findings suggest that this compound may exhibit anti-proliferative effects on certain cancer cell lines. Specifically, it has been shown to inhibit the growth of tumor cells by interfering with key signaling pathways involved in cell division and survival. This makes 2-(piperidin-1-yl)pyridin-3-amine a promising lead compound for further investigation in oncology.

The pharmacological profile of 2-(piperidin-1-yl)pyridin-3-amine is further enhanced by its favorable pharmacokinetic properties. Studies have demonstrated that this compound exhibits good oral bioavailability and a favorable distribution profile, allowing it to reach target tissues effectively. Additionally, its low toxicity and minimal side effects make it a suitable candidate for long-term therapeutic use.

In terms of synthetic chemistry, the preparation of 2-(piperidin-1-yl)pyridin-3-amine has been well-documented in the literature. Various synthetic routes have been developed to produce this compound efficiently and cost-effectively. One common approach involves the reaction of 3-chloropyridine with piperidine in the presence of a suitable base. This method yields high purity products with good yields, making it suitable for large-scale production.

The biological activity of 2-(piperidin-1-yl)pyridin-3-amine has been evaluated through a range of in vitro and in vivo assays. In vitro studies have shown that this compound can effectively bind to specific receptors and enzymes, modulating their activity in a dose-dependent manner. In vivo experiments using animal models have further confirmed these findings, demonstrating that 2-(piperidin-1-yl)pyridin-3-amine can produce significant therapeutic effects without causing adverse reactions.

The potential applications of 2-(piperidin-1-yl)pyridin-3-amine extend beyond traditional pharmaceuticals. Recent advancements in drug delivery systems have opened new avenues for optimizing the therapeutic efficacy of this compound. For example, encapsulating 2-(piperidin-1-y l)pyridin -3 -am ine strong > i n nan o pa rt i c l e s o r l ip os om e s c an enhance its stability and target specificity, leading to improved treatment outcomes. p > < p >I n c on cl us i on ,< s tr on g > 2 -( pi pe ri di n - 1 - y l ) py ri di n - 3 - am ine s tr on g > ( C AS N o .< s tr on g > 50 28 - 14 - 8 s tr on g > ) i s a n i m po r t an t c om po un d w it h m ul ti pl e th er ap eu ti c po t en ti al s . I t s u ni qu e ch em ic al st ru ct ur e an d fa vo ra bl e ph ar ma co lo gi ca l pr op er ti es ma ke i t a pr om is ing ca nd id at e f or d ru g de ve lo pm en t . O ng oi ng re se ar ch w il l co nt in ue t o un co ve r ne w ap pl ic at io ns an d op ti mi ze i ts th er ap eu ti c ef fi ca cy , fu eli ng fu rt he r i n te re st i n t hi s fa sc in ati ng co mp ou nd . p > ar ti cl e > re sp on se >

• 794471-62-8(3,5-Pyridinediamine,2-(2-methyl-1-piperidinyl)-)
• 926219-72-9(2-(3-methylpiperidin-1-yl)pyridin-3-amine)
• 1193388-17-8(2-(piperidin-1-yl)pyridin-3-amine dihydrochloride)
• 756498-58-5(3,5-Pyridinediamine, 2-(1-piperidinyl)-)
• 794471-60-6(3,5-Pyridinediamine,2-(3,5-dimethyl-1-piperidinyl)-)
• 926205-46-1(2-(4-methylpiperidin-1-yl)pyridin-3-amine)
• 5028-13-7(2-(pyrrolidin-1-yl)pyridin-3-amine)
• 94520-29-3(2-(azepan-1-yl)pyridin-3-amine)
• 684649-04-5(3-Pyridinamine, 2,6-bis(hexahydro-1H-azepin-1-yl)-)
• 684648-97-3(3-PYRIDINAMINE, 2-(HEXAHYDRO-1(2H)-AZOCINYL)-)